[ad_1]
Here are some of the biggest movers on Tuesday:
Stock gainers:
-
Bellus Health’s stock
BLU,
+98.42%
soared over 98% during Tuesday premarket trading after U.K. drug giant GSK
GSK,
-0.51% GSK,
-1.11%
said it would acquire the late-clinical-stage biopharmaceutical company for about $2 billion – or $14.75 per share in cash. -
Innoviva’s shares
INVA,
-1.75%
increase by over 10% premarket after the biopharmaceutical company’s pneumonia drug was approved by the FDA Committee last on Monday. The stock was halted earlier on Monday as an FDA panel reviewed the sulbactam-durlobactam drug treatment. -
Shares in Johnson & Johnson
JNJ,
-2.66%
nudged up 1% % after it posted sales and adjusted EPS that beat consensus estimates for its first quarter. The pharmaceutical giant also raised its full-year guidance and boosted its quarterly dividend by 5.3%. -
Bank of America’s stock
BAC,
-0.23%
rose as much as 3% premarket after posting better-than-expected first-quarter revenue and earnings per share. -
Bed Bath & Beyond
BBBY,
+9.07%
continued its rally from Monday, its stock rose as much as 16% premarket on Tuesday. -
Bank of New York Mellon’s stock
BK,
-0.52%
increased as much as 2% premarket after reporting a rise in net income and revenue that matched estimates.
Stock decliners:
-
Goldman Sach’s stock
GS,
-2.99%
dropped over 3% early Tuesday. The investment bank reported a slide in first-quarter revenue that lagged FactSet estimates. -
Regional bank shares such as First Republic Bank
FRC,
-1.86%
and Charles Schwab
SCHW,
-0.53%
were down slightly premarket following a mixed results bag on Monday, when Charles Schwab beat profit expectations but fell short on revenue. -
Plug Power’s shares
PLUG,
-3.16%
declined a modest 0.5% premarket following a downgrade from KeyBanc Capital, which slapped a sector weight rating on the electrical equipment manufacturing company.
[ad_2]
Source link
